# Morningside Group's Biotech Investments: 31 Startups in Its Portfolio (2026) > The 31 Biotech startups Morningside Group has backed, by stage: $2.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/morningside-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 9 - [Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics) - [Cognoa](https://millionrounds.com/company/cognoa) - [Epigenic Therapeutics](https://millionrounds.com/company/epigenic-therapeutics) - [DNAtriX](https://millionrounds.com/company/dnatrix) - [ASLAN Pharmaceuticals](https://millionrounds.com/company/aslan-pharmaceuticals) - [Pinteon Therapeutics](https://millionrounds.com/company/pinteon-therapeutics) - [*X* Xgene](https://millionrounds.com/company/xgene) - [Senhwa Biosciences](https://millionrounds.com/company/senhwa-biosciences) - [Phage Pharm](https://millionrounds.com/company/phage-pharm) ## Series C and later 9 - [AdvanCell](https://millionrounds.com/company/advancell) - [*HB* Heyuan Biotechnology](https://millionrounds.com/company/heyuan-biotechnology) - [Alentis Therapeutics](https://millionrounds.com/company/alentis-therapeutics) - [*B* BioVex](https://millionrounds.com/company/biovex) - [Green Biologics](https://millionrounds.com/company/green-biologics) - [MicuRx Pharmaceuticals](https://millionrounds.com/company/micurx-pharmaceuticals) - [*AB* Accro Bioscience](https://millionrounds.com/company/accro-bioscience) - [ENYO Pharma](https://millionrounds.com/company/enyo-pharma) - [Advanced Cell Diagnostics](https://millionrounds.com/company/advanced-cell-diagnostics) ## Stage not reported 7 - [*Z* ZielBio](https://millionrounds.com/company/zielbio) - [Insilixa](https://millionrounds.com/company/insilixa) - [MedRhythms](https://millionrounds.com/company/medrhythms) - [360Guanxi](https://millionrounds.com/company/360guanxi) - [Endolytix](https://millionrounds.com/company/endolytix) - [EpiVax](https://millionrounds.com/company/epivax) - [VaxEquity](https://millionrounds.com/company/vaxequity) ## Series A 6 - [Avrobio](https://millionrounds.com/company/avrobio) - [Adiso Therapeutics](https://millionrounds.com/company/adiso-therapeutics) - [*M* MobileMD](https://millionrounds.com/company/mobilemd) - [Envisia Therapeutics](https://millionrounds.com/company/envisia-therapeutics) - [Apic Bio](https://millionrounds.com/company/apic-bio) - [Neutrolis](https://millionrounds.com/company/neutrolis) ## Segment by segment ### Series B 9 startups · $415M raised - [**Nocion Therapeutics**](https://millionrounds.com/company/nocion-therapeutics) Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. United States $112M - [**Cognoa**](https://millionrounds.com/company/cognoa) Cognoa is a pediatric behavioral health company founded in 2013, focused on developing digital diagnostics and therapeutics for ch United States $85M - [**Epigenic Therapeutics**](https://millionrounds.com/company/epigenic-therapeutics) Epigenic Therapeutics is a biotechnology company based in China, founded in 2021. China $60M - [**DNAtriX**](https://millionrounds.com/company/dnatrix) DNAtrix is a clinical-stage biotechnology company based in Houston, Texas, with additional operations in San Diego, California. United States $40M - [**ASLAN Pharmaceuticals**](https://millionrounds.com/company/aslan-pharmaceuticals) ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Singapore $39M - [**Pinteon Therapeutics**](https://millionrounds.com/company/pinteon-therapeutics) Pinteon is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. United States $29M - [*X* **Xgene**](https://millionrounds.com/company/xgene) China $20M - [**Senhwa Biosciences**](https://millionrounds.com/company/senhwa-biosciences) Senhwa is a drug development company creating innovative therapies for cancer and related diseases. United States $17M ### Series C and later 9 startups · $1.4B raised - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [*HB* **Heyuan Biotechnology**](https://millionrounds.com/company/heyuan-biotechnology) Heyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services. China $300M - [**Alentis Therapeutics**](https://millionrounds.com/company/alentis-therapeutics) Alentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland. Switzerland $194M - [*B* **BioVex**](https://millionrounds.com/company/biovex) THOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquis United Kingdom $133M - [**Green Biologics**](https://millionrounds.com/company/green-biologics) Green Biologics offers fermentation technologies for the conversion of biomass to renewable fuels and chemicals. United Kingdom $118M - [**MicuRx Pharmaceuticals**](https://millionrounds.com/company/micurx-pharmaceuticals) MicuRx discovers and develops novel antimicrobials to treat drug-resistant infections and other diseases of significant unmet medi United States $90M - [*AB* **Accro Bioscience**](https://millionrounds.com/company/accro-bioscience) China $64M - [**ENYO Pharma**](https://millionrounds.com/company/enyo-pharma) ENYO Pharma is a clinical-stage biopharmaceutical company based in Lyon, France. France $54M ### Stage not reported 7 startups · $71M raised - [*Z* **ZielBio**](https://millionrounds.com/company/zielbio) ZielBio is an early-stage biotechnology company that identifies novel high-value disease targets and develops therapeutic interven United States $33M - [**Insilixa**](https://millionrounds.com/company/insilixa) InSilixa is a private biotechnology and diagnostics company located in Sunnyvale, California. United States $13M - [**MedRhythms**](https://millionrounds.com/company/medrhythms) Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking. United States $9.6M - [**360Guanxi**](https://millionrounds.com/company/360guanxi) 360Guanxi is an integrated media company that caters to Chinese chemical, pharmaceutical, and life science industries. China $5.0M - [**Endolytix**](https://millionrounds.com/company/endolytix) Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections. United States $5.0M - [**EpiVax**](https://millionrounds.com/company/epivax) EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology. United States $4.9M - [**VaxEquity**](https://millionrounds.com/company/vaxequity) VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines. United States $870K ### Series A 6 startups · $302M raised - [**Avrobio**](https://millionrounds.com/company/avrobio) Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. United States $85M - [**Adiso Therapeutics**](https://millionrounds.com/company/adiso-therapeutics) Adiso Therapeutics develops medications to treat inflammatory diseases. United States $60M - [*M* **MobileMD**](https://millionrounds.com/company/mobilemd) China $48M - [**Envisia Therapeutics**](https://millionrounds.com/company/envisia-therapeutics) Envisia Therapeutics is a biotechnology company based in Research Triangle Park, North Carolina, established in 2013 by Liquidia T United States $46M - [**Apic Bio**](https://millionrounds.com/company/apic-bio) Apic Bio, Inc. United States $40M - [**Neutrolis**](https://millionrounds.com/company/neutrolis) Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs). United States $23M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Morningside Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Morningside Group's AI portfolio** 11 startups · $1.8B](https://millionrounds.com/portfolio-maps/morningside-ai-portfolio)[Portfolio map **Morningside Group portfolio map** 79 startups · $11B](https://millionrounds.com/portfolio-maps/morningside-portfolio-map)[Co-investors **Who invests with Morningside Group** 39 co-investors](https://millionrounds.com/portfolio-maps/morningside-co-investors)[Investments abroad **Morningside Group's investments in China** 23 startups · $5.7B](https://millionrounds.com/portfolio-maps/morningside-investments-china)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio) ## Raising from investors like Morningside Group? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)